simplyStocks
Insulet
PODD · NASDAQMedical Devices
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$10.4B
Revenue (FY25)
$2.7B
Rev. growth
+31%
Net income
$247M
Gross margin
~72%
Segment
Diabetes devices
Flagship
Omnipod 5
Listing
NASDAQ
In plain English
Insulet makes the Omnipod — a small, tubeless, wearable insulin pump that sticks to the skin and is controlled by phone. Its Omnipod 5 reads a continuous glucose monitor from Dexcom or Abbott and automatically doses insulin, turning diabetes management into a near-hands-free 'closed loop.' The disposable pods are a razor-and-blades business: patients replace one every few days, so revenue compounds with every new user.
In simple terms
What Insulet really sells
Insulet makes the Omnipod — a small, tubeless, wearable insulin pump that sticks to the skin and is controlled by phone. Its Omnipod 5 reads a continuous glucose monitor from Dexcom or Abbott and automatically doses insulin, turning diabetes management into a near-hands-free 'closed loop.' The disposable pods are a razor-and-blades business: patients replace one every few days, so revenue compounds with every new user.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
SteadierMore speculative
Why this rating?